More SEC Filings
View Older Stories View Newer Stories-
Form SCHEDULE 13G/A Context Therapeutics Filed by: Deep Track Capital, LP
-
Form D DAVID DEALIO JENKINS
-
Form 13F-HR 2Xideas AG For: Mar 31
-
Form 10-Q Transit Pro Tech Inc. For: Mar 31
-
Form 13F-NT State Street Saudi Arabi For: Mar 31
-
Form MA-I PIPER SANDLER & CO.
-
Form SCHEDULE 13G/A BICYCLE THERAPEUTICS Filed by: Deep Track Capital, LP
-
Form MA-I/A First Tryon Advisors,
-
Form MA-I/A First Tryon Advisors,
-
Form MA-I/A First Tryon Advisors,
-
Form MA-I/A First Tryon Advisors,
-
Form SCHEDULE 13G/A Allakos Inc. Filed by: Deep Track Capital, LP
-
Form 6-K DOLLY VARDEN SILVER CORP For: May 15
-
Form MA-I/A Masterson Advisors LLC
-
Form MA-I/A FIRST HAWAIIAN BANK
-
Form 8-K GRI Bio, Inc. For: May 15
-
Form 6-K KB Financial Group Inc. For: May 15
-
Form 13F-NT CIGOGNE MANAGEMENT SA For: Mar 31
-
Form 10-Q Lantern Pharma Inc. For: Mar 31
-
Form 10-Q Glimpse Group, Inc. For: Mar 31
-
Form 8-K ADIAL PHARMACEUTICALS, For: May 15
-
Form 10-Q KINETA, INC./DE For: Mar 31
-
Form 8-K TruGolf Holdings, Inc. For: May 14
-
Form 8-K Glimpse Group, Inc. For: May 15
-
Form SCHEDULE 13G/A Regulus Therapeutics Filed by: Vivo Opportunity Fund Holdings, L.P.
-
Form 10-D WFN CREDIT CO LLC For: Apr 30
-
Form SCHEDULE 13G TENAX THERAPEUTICS, INC. Filed by: RTW INVESTMENTS, LP
-
Form SCHEDULE 13G/A SERA PROGNOSTICS, INC. Filed by: Vivo Capital IX, LLC
-
Form 6-K Bitdeer Technologies For: May 15
-
Form 13F-HR Oakcliff Capital Partner For: Mar 31
-
Form SCHEDULE 13G/A DELCATH SYSTEMS, INC. Filed by: Vivo Opportunity Fund Holdings, L.P.
-
Form 13F-HR Godshalk Welsh Capital For: Mar 31
-
Form NT 10-Q YUNHONG GREEN CTI LTD. For: Mar 31
-
Form SCHEDULE 13G/A COMPASS Pathways plc Filed by: Vivo Opportunity Fund Holdings, L.P.
-
Form 13F-NT State Street Global Advi For: Mar 31
-
Form 8-K Angel Oak Financial Stra For: May 15
-
Form SCHEDULE 13G/A Cidara Therapeutics, Filed by: Vivo Opportunity Fund Holdings, L.P.
-
Form 8-K Lantern Pharma Inc. For: May 15
-
Form 10-Q CLOUDASTRUCTURE, INC. For: Mar 31
-
Form 10-Q Cocrystal Pharma, Inc. For: Mar 31
-
Form 8-K Cocrystal Pharma, Inc. For: May 15
-
Form 10-Q Workhorse Group Inc. For: Mar 31
-
Form SCHEDULE 13G/A Knightscope, Inc. Filed by: Santana Li William
-
Form SCHEDULE 13G/A Unicycive Therapeutics, Filed by: Vivo Opportunity Fund Holdings, L.P.
-
Form 8-K Beeline Holdings, Inc. For: May 15
-
Form 8-K HeartCore Enterprises, For: May 15
-
Form 6-K Digi Power X Inc. For: May 15
-
Form 8-K Vaxart, Inc. For: May 15
-
Form 13F-HR Aster Capital Management For: Mar 31
-
Form 424B2 JPMORGAN CHASE & CO

